(Credit: Igor Stevanovic/iStockphoto)

Pear Therapeutics' ReSET-O app has been cleared by the Food and Drug Administration (FDA) to aid in the retention of individuals in outpatient treatment for opioid use disorder (OUD).

The app provides cognitive behavioral therapy (CBT) to recovering opioid addicts. It is meant to be used in conjunction with outpatient treatment that includes medication-assisted treatment and contingency management.

Clinically supervised patients 18 years or older can use the "prescription-only mobile medical application," according to Pear Therapeutics' press release.

SEE: 'Hey, Charlie' uses text alerts to help recovering addicts stay sober

ReSET-O is specifically designed for opioid recovery, while it's sister app Reset. The app helps to treat addiction or abuse of substances like cocaine, alcohol, or stimulants. Reset gained FDA approval in January.

"Digital technologies and data science have incredible potential to unlock the next chapter of medical innovation and to help individuals finally take control of their own health in a meaningful way," Richard Francis, CEO of Sandoz Inc. said. "New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their therapies and thus improve patient outcomes. At Sandoz, we are proud to be a joint pioneer in this exciting new field."

ReSET-O is a 12-week prescription digital therapeutic for opioid abuse that works similarly to the Community Reinforcement Approach. Users participate in a series of interactive therapy sessions that use CBT and skill-building exercises via text, audio, video, animations, and graphics.

ReSET-O is supplementary to traditional treatment for opioid abuse. Patients can keep better records between doctor visits by logging when they experience cravings, triggers, and whether they're taking or not taking their prescribed buprenorphine.

Patients dropping out of treatment and relapsing is a significant problem that opioid treatment providers face, according to Pear Therapeutics.

The app's goal, in tandem with traditional treatment methods, is to increase retention rates in programs. reached out to Pear Therapeutics for comment. We'll update when we hear back.

FOLLOW on Twitter for all the latest app news.


  1. Pear Therapeutics' ReSET-O opioid addiction recovery app gained FDA approval.
  2. Patients can self-report cravings, triggers, and when they take their medicine in the app, which works in tandem with traditional treatment methods to help patient recovery retention rates.

Also see

Shelby is an Associate Writer for CNET's She served as Editor in Chief for the Louisville Cardinal newspaper at the University of Louisville. She interned as Creative Non-Fiction Editor for Miracle Monocle literary magazine. Her work appears in Glass Mountain Magazine, Bookends Review, Soundings East, and on Her cat, Puck, is the best cat ever.